Annual CFO
-$6.69 M
+$6.85 M+50.59%
31 March 2024
Summary:
Biotricity annual cash flow from operations is currently -$6.69 million, with the most recent change of +$6.85 million (+50.59%) on 31 March 2024. During the last 3 years, it has risen by +$4.39 million (+39.59%). BTCY annual CFO is now -81532.93% below its all-time high of -$8200.00, reached on 01 August 2014.BTCY Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$397.10 K
+$1.10 M+73.42%
30 September 2024
Summary:
Biotricity quarterly cash flow from operations is currently -$397.10 thousand, with the most recent change of +$1.10 million (+73.42%) on 30 September 2024. Over the past year, it has increased by +$1.99 million (+83.38%). BTCY quarterly CFO is now -10930.56% below its all-time high of -$3600.00, reached on 30 November 2014.BTCY Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$4.36 M
+$1.99 M+31.35%
30 September 2024
Summary:
Biotricity TTM cash flow from operations is currently -$4.36 million, with the most recent change of +$1.99 million (+31.35%) on 30 September 2024. Over the past year, it has increased by +$4.92 million (+52.98%). BTCY TTM CFO is now -121097.22% below its all-time high of -$3600.00, reached on 30 November 2014.BTCY TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BTCY Cash From Operations Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +50.6% | +83.4% | +53.0% |
3 y3 years | +39.6% | +87.7% | +65.0% |
5 y5 years | -28.2% | +72.8% | +18.3% |
BTCY Cash From Operations High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +55.9% | at high | +91.7% | at high | +75.4% |
5 y | 5 years | -28.2% | +55.9% | at high | +91.7% | at high | +75.4% |
alltime | all time | <-9999.0% | +55.9% | <-9999.0% | +91.7% | <-9999.0% | +75.4% |
Biotricity Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$397.10 K(-73.4%) | -$4.36 M(-31.4%) |
June 2024 | - | -$1.49 M(+28.2%) | -$6.36 M(-5.0%) |
Mar 2024 | -$6.69 M(-50.6%) | -$1.17 M(-10.7%) | -$6.69 M(-9.6%) |
Dec 2023 | - | -$1.31 M(-45.4%) | -$7.41 M(-20.2%) |
Sept 2023 | - | -$2.39 M(+30.5%) | -$9.28 M(-18.2%) |
June 2023 | - | -$1.83 M(-2.5%) | -$11.34 M(-16.3%) |
Mar 2023 | -$13.55 M(-10.7%) | -$1.88 M(-40.9%) | -$13.55 M(-17.5%) |
Dec 2022 | - | -$3.18 M(-28.6%) | -$16.42 M(-7.4%) |
Sept 2022 | - | -$4.45 M(+10.2%) | -$17.73 M(+7.3%) |
June 2022 | - | -$4.04 M(-15.1%) | -$16.52 M(+9.0%) |
Mar 2022 | -$15.16 M(+36.8%) | -$4.76 M(+6.0%) | -$15.16 M(+8.4%) |
Dec 2021 | - | -$4.49 M(+38.5%) | -$13.99 M(+12.2%) |
Sept 2021 | - | -$3.24 M(+20.8%) | -$12.47 M(+9.7%) |
June 2021 | - | -$2.68 M(-25.1%) | -$11.37 M(+2.6%) |
Mar 2021 | -$11.08 M(+40.9%) | -$3.58 M(+20.4%) | -$11.08 M(+6.0%) |
Dec 2020 | - | -$2.97 M(+39.1%) | -$10.45 M(+8.9%) |
Sept 2020 | - | -$2.14 M(-10.7%) | -$9.60 M(+7.5%) |
June 2020 | - | -$2.39 M(-19.0%) | -$8.93 M(+13.5%) |
Mar 2020 | -$7.86 M | -$2.95 M(+39.4%) | -$7.86 M(+29.6%) |
Dec 2019 | - | -$2.12 M(+44.9%) | -$6.07 M(+13.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2019 | - | -$1.46 M(+10.1%) | -$5.34 M(+0.0%) |
June 2019 | - | -$1.33 M(+14.8%) | -$5.34 M(+2.3%) |
Mar 2019 | -$5.22 M(+7.1%) | -$1.16 M(-16.9%) | -$5.22 M(-8.4%) |
Dec 2018 | - | -$1.39 M(-4.7%) | -$5.70 M(+6.8%) |
Sept 2018 | - | -$1.46 M(+20.8%) | -$5.34 M(+11.2%) |
June 2018 | - | -$1.21 M(-26.1%) | -$4.80 M(-1.5%) |
Mar 2018 | -$4.87 M(+30.0%) | -$1.64 M(+59.2%) | -$4.87 M(+50.6%) |
Dec 2017 | - | -$1.03 M(+11.4%) | -$3.24 M(+14.3%) |
Sept 2017 | - | -$923.20 K(-28.2%) | -$2.83 M(+11.3%) |
June 2017 | - | -$1.28 M(+105.8%) | -$2.54 M(+6.7%) |
Mar 2017 | -$3.75 M(+57.3%) | - | - |
Dec 2016 | -$2.38 M(+21.4%) | -$624.40 K(-1.7%) | -$2.38 M(+34.3%) |
Sept 2016 | - | -$634.90 K(+10.8%) | -$1.77 M(+55.7%) |
June 2016 | - | -$572.80 K(+3.9%) | -$1.14 M(+101.0%) |
Mar 2016 | - | -$551.50 K(+3390.5%) | -$567.30 K(+3490.5%) |
Dec 2015 | -$1.96 M(+7174.1%) | - | - |
Nov 2015 | - | -$15.80 K(+338.9%) | -$15.80 K(+338.9%) |
Aug 2015 | -$27.00 K(+229.3%) | - | - |
Nov 2014 | - | -$3600.00 | -$3600.00 |
Aug 2014 | -$8200.00 | - | - |
FAQ
- What is Biotricity annual cash flow from operations?
- What is the all time high annual CFO for Biotricity?
- What is Biotricity annual CFO year-on-year change?
- What is Biotricity quarterly cash flow from operations?
- What is the all time high quarterly CFO for Biotricity?
- What is Biotricity quarterly CFO year-on-year change?
- What is Biotricity TTM cash flow from operations?
- What is the all time high TTM CFO for Biotricity?
- What is Biotricity TTM CFO year-on-year change?
What is Biotricity annual cash flow from operations?
The current annual CFO of BTCY is -$6.69 M
What is the all time high annual CFO for Biotricity?
Biotricity all-time high annual cash flow from operations is -$8200.00
What is Biotricity annual CFO year-on-year change?
Over the past year, BTCY annual cash flow from operations has changed by +$6.85 M (+50.59%)
What is Biotricity quarterly cash flow from operations?
The current quarterly CFO of BTCY is -$397.10 K
What is the all time high quarterly CFO for Biotricity?
Biotricity all-time high quarterly cash flow from operations is -$3600.00
What is Biotricity quarterly CFO year-on-year change?
Over the past year, BTCY quarterly cash flow from operations has changed by +$1.99 M (+83.38%)
What is Biotricity TTM cash flow from operations?
The current TTM CFO of BTCY is -$4.36 M
What is the all time high TTM CFO for Biotricity?
Biotricity all-time high TTM cash flow from operations is -$3600.00
What is Biotricity TTM CFO year-on-year change?
Over the past year, BTCY TTM cash flow from operations has changed by +$4.92 M (+52.98%)